EP1827461
Kladribín meðferðaráform til meðhöndlunar á heila- og mænusiggi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.12.2005EP published:
29.2.2012EP application number:
05823474.1
EP translation filed:
2.5.2012Grant published:
15.5.2012EPO information:
European Patent Register
Max expiry date:
19.12.2025Expiry date:
19.12.2014
Title:
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
Timeline
Today
20.12.2005EP application
29.2.2012EP Publication
2.5.2012Translation submitted
15.5.2012Registration published
19.12.2014Expires
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, 1267, Coinsins, Vaud, CH
Inventor
Name:
DE LUCA, GiampieroAddress:
Conches, CH
Name:
YTHIER, ArnaudAddress:
Collex-Bossy, CH
Name:
MUNAFO, AlainAddress:
Tartegnin, CH
Name:
LOPEZ-BRESNAHAN, MariaAddress:
Lincoln, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
638669 PDate:
22.12.2004Country:
US
Number:
04106909Date:
22.12.2004Country:
EP
Classification
Categories:
A61K 31/7076, A61K 38/21, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.11.2012
Expires: 19.12.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 6.11.2013
Expires: 19.12.2014
Payer: Árnason Faktor